Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 19,806 | 23,335 | 21,274 | 22,312 |
| Cost of Goods | N/A | 7,483 | 8,070 | 6,755 | 7,710 |
| Gross Profit | N/A | 12,323 | 15,265 | 14,519 | 14,602 |
| Operating Expenses | 7,248 | 14,568 | 15,132 | 16,676 | 17,590 |
| Operating Income | -7,248 | -1,762 | 203 | -1,402 | -2,278 |
| Interest Expense | 0 | 249 | 389 | 498 | 576 |
| Other Income | -43 | -9 | -137 | 889 | -31 |
| Pre-tax Income | -7,291 | -2,020 | -323 | -1,011 | -2,885 |
| Income Tax | 0 | 27 | -64 | 66 | 38 |
| Net Income Continuous | -7,291 | -2,047 | -259 | -1,077 | -2,923 |
| Net Income | $-7,291 | $-2,047 | $-259 | $-1,077 | $-2,923 |
| EPS Basic Total Ops | -3,073.46 | -10,794.60 | -1,499.25 | -6,746.63 | -23,088.46 |
| EPS Basic Continuous Ops | -3,107.53 | -10,674.66 | -1,444.59 | -6,612.17 | -23,028.42 |
| EPS Diluted Total Ops | -3,073.46 | -10,794.60 | -1,499.25 | -6,746.63 | -23,088.46 |
| EPS Diluted Continuous Ops | -3,107.53 | -10,674.66 | -1,444.59 | -6,612.17 | -23,028.42 |
| EPS Diluted Before Non-Recurring Items | -17,991.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,150 | $1,965 | $3,287 | $975 | $645 |